Kensington Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKQ Corp
LKQ
|
+$807K |
| 2 |
Snap-on
SNA
|
+$739K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$697K |
| 4 |
Monster Beverage
MNST
|
+$649K |
| 5 |
Watsco Inc
WSO
|
+$607K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$1.27M |
| 2 |
Walmart Inc
WMT
|
+$796K |
| 3 |
Procter & Gamble
PG
|
+$761K |
| 4 |
Edwards Lifesciences
EW
|
+$506K |
| 5 |
Coca-Cola
KO
|
+$456K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.72% |
| 2 | Industrials | 18.73% |
| 3 | Healthcare | 16.32% |
| 4 | Consumer Discretionary | 13.41% |
| 5 | Financials | 9.33% |
Similar funds
Kensington Investment Counsel's Q1 2024 Portfolio in Review
As of Q1 2024, Kensington Investment Counsel held 102 positions worth $219M, up 15% from $191M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Kensington Investment Counsel deployed $10.4M of net new capital in Q1 2024, opening 5 new positions and adding to 67 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 1,648 shares worth $689K.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Starbucks, an estimated $1.27M trimmed.
- Kensington Investment Counsel's largest Q1 2024 buy was Vertex Pharmaceuticals: 1,648 shares worth $689K.
- Kensington Investment Counsel added most to LKQ Corp in Q1 2024, an estimated $807K increase.
- Kensington Investment Counsel's biggest Q1 2024 reduction was Starbucks, cutting an estimated $1.27M.
- Kensington Investment Counsel fully exited Coca-Cola in Q1 2024, selling an estimated $456K.
- Kensington Investment Counsel's ten largest holdings make up 32% of its $219M portfolio in Q1 2024.
- Kensington Investment Counsel opened 5 new positions and closed 5 in Q1 2024.
- Kensington Investment Counsel's portfolio value rose 15% quarter-over-quarter to $219M.
Based on Kensington Investment Counsel's 13F filing for Q1 2024, filed 13 May 2024.